Literature DB >> 27030368

Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease.

Xin Hu1, Jaimee R Compton2, Dagmar H Leary3, Mark A Olson4, Michael S Lee4, Jonah Cheung5, Wenjuan Ye1, Mark Ferrer1, Noel Southall1, Ajit Jadhav1, Elaine M Morazzani4, Pamela J Glass4, Juan Marugan1, Patricia M Legler3.   

Abstract

The Venezuelan equine encephalitis virus (<span class="Species">VEEV) nonstructural protein 2 (nsP2) cysteine protease (EC 3.4.22.-) is essential for viral replication and is involved in the cytopathic effects (CPE) of the virus. The VEEV nsP2 protease is a member of MEROPS Clan CN and characteristically contains a papain-like protease linked to an S-adenosyl-l-methionine-dependent RNA methyltransferase (SAM MTase) domain. The protease contains an alternative active site motif, (475)NVCWAK(480), which differs from papain's (CGS(25)CWAFS), and the enzyme lacks a transition state-stabilizing residue homologous to Gln-19 in papain. To understand the roles of conserved residues in catalysis, we determined the structure of the free enzyme and the first structure of an inhibitor-bound alphaviral protease. The peptide-like E64d inhibitor was found to bind beneath a β-hairpin at the interface of the SAM MTase and protease domains. His-546 adopted a conformation that differed from that found in the free enzyme; one or both of the conformers may assist in leaving group departure of either the amine or Cys thiolate during the catalytic cycle. Interestingly, E64c (200 μM), the carboxylic acid form of the E64d ester, did not inhibit the nsP2 protease. To identify key residues involved in substrate binding, a number of mutants were analyzed. Mutation of the motif residue, N475A, led to a 24-fold reduction in kcat/Km, and the conformation of this residue did not change after inhibition. N475 forms a hydrogen bond with R662 in the SAM MTase domain, and the R662A and R662K mutations both led to 16-fold decreases in kcat/Km. N475 forms the base of the P1 binding site and likely orients the substrate for nucleophilic attack or plays a role in product release. An Asn homologous to N475 is similarly found in coronaviral papain-like proteases (PLpro) of the Severe Acute Respiratory Syndrome (SARS) virus and Middle East Respiratory Syndrome (MERS) virus. Mutation of another motif residue, K480A, led to a 9-fold decrease in kcat and kcat/Km. K480 likely enhances the nucleophilicity of the Cys. Consistent with our substrate-bound models, the SAM MTase domain K706A mutation increased Km 4.5-fold to 500 μM. Within the β-hairpin, the N545A mutation slightly but not significantly increased kcat and Km. The structures and identified active site residues may facilitate the discovery of protease inhibitors with antiviral activity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27030368      PMCID: PMC5290728          DOI: 10.1021/acs.biochem.5b00992

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  68 in total

1.  Detection of six serotypes of botulinum neurotoxin using fluorogenic reporters.

Authors:  Daniel R Ruge; F Mark Dunning; Timothy M Piazza; Brian E Molles; Michael Adler; Füsûn N Zeytin; Ward C Tucker
Journal:  Anal Biochem       Date:  2011-01-07       Impact factor: 3.365

2.  The crystal structure of the Venezuelan equine encephalitis alphavirus nsP2 protease.

Authors:  Andrew T Russo; Mark A White; Stanley J Watowich
Journal:  Structure       Date:  2006-09       Impact factor: 5.006

3.  The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.

Authors:  Natalia Garmashova; Rodion Gorchakov; Eugenia Volkova; Slobodan Paessler; Elena Frolova; Ilya Frolov
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

4.  Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice.

Authors:  A B Ryzhikov; N V Tkacheva; A N Sergeev; E I Ryabchikova
Journal:  Biomed Sci       Date:  1991

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

7.  Nuclear import and export of Venezuelan equine encephalitis virus nonstructural protein 2.

Authors:  Stephanie A Montgomery; Robert E Johnston
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

8.  Processing the nonstructural polyproteins of sindbis virus: nonstructural proteinase is in the C-terminal half of nsP2 and functions both in cis and in trans.

Authors:  W R Hardy; J H Strauss
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Modulation of GSK-3β activity in Venezuelan equine encephalitis virus infection.

Authors:  Kylene Kehn-Hall; Aarthi Narayanan; Lindsay Lundberg; Gavin Sampey; Chelsea Pinkham; Irene Guendel; Rachel Van Duyne; Svetlana Senina; Kimberly L Schultz; Eric Stavale; M Javad Aman; Charles Bailey; Fatah Kashanchi
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

10.  Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.

Authors:  Kiira Ratia; Andrew Kilianski; Yahira M Baez-Santos; Susan C Baker; Andrew Mesecar
Journal:  PLoS Pathog       Date:  2014-05-22       Impact factor: 6.823

View more
  8 in total

1.  Design and Validation of Novel Chikungunya Virus Protease Inhibitors.

Authors:  Pratyush Kumar Das; Laura Puusepp; Finny S Varghese; Age Utt; Tero Ahola; Dzmitry G Kananovich; Margus Lopp; Andres Merits; Mati Karelson
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

2.  Proteolytic cleavage of host proteins by the Group IV viral proteases of Venezuelan equine encephalitis virus and Zika virus.

Authors:  Elaine M Morazzani; Jaimee R Compton; Dagmar H Leary; Angela V Berry; Xin Hu; Juan J Marugan; Pamela J Glass; Patricia M Legler
Journal:  Antiviral Res       Date:  2019-02-10       Impact factor: 10.103

3.  Structural insights into the inhibition of the nsP2 protease from Chikungunya virus by molecular modeling approaches.

Authors:  Vitor Won-Held Rabelo; Izabel Christina Nunes de Palmer Paixão; Paula Alvarez Abreu
Journal:  J Mol Model       Date:  2022-09-12       Impact factor: 2.172

4.  Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease's active site cysteine residue.

Authors:  Kai Rausalu; Age Utt; Tania Quirin; Finny S Varghese; Eva Žusinaite; Pratyush Kumar Das; Tero Ahola; Andres Merits
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

Review 5.  Nonstructural Proteins of Alphavirus-Potential Targets for Drug Development.

Authors:  Farhana Abu Bakar; Lisa F P Ng
Journal:  Viruses       Date:  2018-02-09       Impact factor: 5.048

6.  In vitro study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases.

Authors:  Raphael J Eberle; Danilo S Olivier; Carolina C Pacca; Clarita M S Avilla; Mauricio L Nogueira; Marcos S Amaral; Dieter Willbold; Raghuvir K Arni; Monika A Coronado
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

7.  Turnip yellow mosaic virus protease binds ubiquitin suboptimally to fine-tune its deubiquitinase activity.

Authors:  Sonia Fieulaine; Martin D Witte; Christopher S Theile; Maya Ayach; Hidde L Ploegh; Isabelle Jupin; Stéphane Bressanelli
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

8.  Specificity Studies of the Venezuelan Equine Encephalitis Virus Non-Structural Protein 2 Protease Using Recombinant Fluorescent Substrates.

Authors:  Beáta Bozóki; János András Mótyán; Gyula Hoffka; David S Waugh; József Tőzsér
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.